Bjarke Viberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bjarke Viberg has a total of 344 co-authors. Here are the top co-authors by number of shared publications:
- Søren Overgaard
Department of Orthopaedic Surgery and Traumatology, Copenhagen University Hospital, Bispebjerg, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
16 shared publications - Per Hviid Gundtoft
Department of Orthopedic Surgery and Traumatology, Hospital Lillebaelt Kolding, University Hospital of Southern Denmark; Department of Orthopedic Surgery and Traumatology, Aarhus University Hospital, Aarhus, Denmark
13 shared publications Henrik Palm
Department of Orthopaedic Surgery and Traumatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Capital Region of Denmark, Denmark
9 shared publications- Henrik Palm
Department of Orthopaedic Surgery, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark
8 shared publications - Cecilia Rogmark
Department of Orthopaedics, Lund University, Skane University Hospital, Malmö, Sweden
7 shared publications Per Hviid Gundtoft
Department of Orthopaedic Surgery and Traumatology, Hospital Lillebaelt Kolding – University Hospital of Southern Denmark, Kolding; Department of Orthopaedic Surgery and Traumatology, Aarhus University Hospital, Aarhus
7 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 595–601
Nordic hip fracture registries: comparisons toward a minimal common and standardized Nordic Hip Fracture Dataset (Nordic-HFD)
Background and purpose: National hip fracture registries in Denmark, Norway, and Sweden collect extensive pre- and post-fracture data. Inspired by the Global Fragility Fracture Network (Global FFN) minimum common dataset, which is not specifically tailored to Nordic healthcare systems, we aimed to evaluate the feasibility of developing a standardized Nordic Hip Fracture Dataset (Nordic-HFD).Methods: We compared 4 Nordic hip fracture registries: the Danish Multidisciplinary Hip Fracture Registry, the Norwegian Hip Fracture Register, the Swedish Fracture Register, and the Swedish Hip Fracture Register (RIKSHÖFT). Variables available in at least 3 registries, including those obtainable through linkage with national health registries, were assessed for definitions and grouped into demographic, surgical, postoperative, complications, and PROM domains.Results: Across registries, 38 variables were identified. The number of variables available in all 4 registries was 11, while 31 were available in at least 3 registries. After quality review, 30 variables were ultimately considered suitable for inclusion in the proposed Nordic-HFD.Demographic variables such as age, sex, fracture type, pathological fracture, laterality, ASA score, surgical variables such as surgical method, date of surgery, time to surgery, and mortality were directly comparable. Variables on mobility, cognitive impairment, complications, and PROMs may require further harmonization.Conclusion: Establishing a Nordic-HFD is feasible using existing national registries’ infrastructures. The remaining challenge is harmonizing variable definitions to specific research questions and future validation studies. A Nordic-HFD would enhance robust cross-country benchmarking and support international initiatives such as the Global FFN.
- 3 September 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 595–601
Open AccessNordic hip fracture registries: comparisons toward a minimal common and standardized Nordic Hip Fracture Dataset (Nordic-HFD)
Background and purpose: National hip fracture registries in Denmark, Norway, and Sweden collect extensive pre- and post-fracture data. Inspired by the Global Fragility Fracture Network (Global FFN) minimum common dataset, which is not specifically tailored to Nordic healthcare systems, we aimed to evaluate the feasibility of developing a standardized Nordic Hip Fracture Dataset (Nordic-HFD).Methods: We compared 4 Nordic hip fracture registries: the Danish Multidisciplinary Hip Fracture Registry, the Norwegian Hip Fracture Register, the Swedish Fracture Register, and the Swedish Hip Fracture Register (RIKSHÖFT). Variables available in at least 3 registries, including those obtainable through linkage with national health registries, were assessed for definitions and grouped into demographic, surgical, postoperative, complications, and PROM domains.Results: Across registries, 38 variables were identified. The number of variables available in all 4 registries was 11, while 31 were available in at least 3 registries. After quality review, 30 variables were ultimately considered suitable for inclusion in the proposed Nordic-HFD.Demographic variables such as age, sex, fracture type, pathological fracture, laterality, ASA score, surgical variables such as surgical method, date of surgery, time to surgery, and mortality were directly comparable. Variables on mobility, cognitive impairment, complications, and PROMs may require further harmonization.Conclusion: Establishing a Nordic-HFD is feasible using existing national registries’ infrastructures. The remaining challenge is harmonizing variable definitions to specific research questions and future validation studies. A Nordic-HFD would enhance robust cross-country benchmarking and support international initiatives such as the Global FFN.
- Open Access
- 22 July 2026
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 27 (9) , 106384
Effect of an Integrated Postdischarge Care Program for Older Patients After Hip Fracture Discharged to the Community: A Multicenter Cohort Study
- 22 July 2026
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 27 (9) , 106384
Open AccessEffect of an Integrated Postdischarge Care Program for Older Patients After Hip Fracture Discharged to the Community: A Multicenter Cohort Study
- Open Access
The effects of intravenous iron on mobility in older adults following hip fracture surgery: protocol for a multicentre, parallel group, randomised controlled trial - the IronHip trial.
Half of all patients with a hip fracture (HF) do not recover their pre-fracture mobility after 1 year. Mobility and functional capabilities may be impaired by postoperative low haemoglobin levels and iron deficiency. The primary objective of this trial is to compare the effect of a single postoperative dose of ferric derisomaltose 20 mg/kg body weight relative to placebo on the recovery of functional mobility in patients. The IronHip trial is a multicentre, randomised, double-blind, placebo-controlled trial with participants allocated in a 1:1 ratio to receive intravenous iron or placebo. The eligible population is participants aged 65 years or older who have undergone HF surgery and have a haemoglobin concentration below 105 g/L measured between postoperative day 1 and 5. In total, 210 participants will be randomised. Main analyses will be conducted in the intention-to-treat population using a mixed model for repeated measures, including assessments at baseline and at 4, 6 and 12 weeks after randomisation. Treatment effects will be estimated from the treatment-by-time interaction and reported as between-group differences in least-squares mean New Mobility Score with 95% CIs. The secondary outcomes are haemoglobin, red blood cell transfusions, fatigue, quality of life, self-rated health, fear of falls, 30 s sit-to-stand test, activities of daily living, pain, days alive and at home up to 30 days, mortality and serious adverse events. Exploratory outcomes are cost-effectiveness, physical activity, hand grip strength, knee extension strength, cognition, ferritin and transferrin saturation. Recruitment was initiated on 9 June 2025. The IronHip trial has been approved by the Danish Medicines Agency and the Danish Medical Research Ethics Committee. The protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines, the Declaration of Helsinki and the Good Clinical Practice guidelines. The trial findings will be reported according to the Consolidated Standards of Reporting Trials (CONSORT) statement in peer-reviewed journals. EU CT number: 2024-5 15 116-42-00, authorised 9 February 2025. gov: NCT06898814.
Open AccessThe effects of intravenous iron on mobility in older adults following hip fracture surgery: protocol for a multicentre, parallel group, randomised controlled trial - the IronHip trial.
Half of all patients with a hip fracture (HF) do not recover their pre-fracture mobility after 1 year. Mobility and functional capabilities may be impaired by postoperative low haemoglobin levels and iron deficiency. The primary objective of this trial is to compare the effect of a single postoperative dose of ferric derisomaltose 20 mg/kg body weight relative to placebo on the recovery of functional mobility in patients. The IronHip trial is a multicentre, randomised, double-blind, placebo-controlled trial with participants allocated in a 1:1 ratio to receive intravenous iron or placebo. The eligible population is participants aged 65 years or older who have undergone HF surgery and have a haemoglobin concentration below 105 g/L measured between postoperative day 1 and 5. In total, 210 participants will be randomised. Main analyses will be conducted in the intention-to-treat population using a mixed model for repeated measures, including assessments at baseline and at 4, 6 and 12 weeks after randomisation. Treatment effects will be estimated from the treatment-by-time interaction and reported as between-group differences in least-squares mean New Mobility Score with 95% CIs. The secondary outcomes are haemoglobin, red blood cell transfusions, fatigue, quality of life, self-rated health, fear of falls, 30 s sit-to-stand test, activities of daily living, pain, days alive and at home up to 30 days, mortality and serious adverse events. Exploratory outcomes are cost-effectiveness, physical activity, hand grip strength, knee extension strength, cognition, ferritin and transferrin saturation. Recruitment was initiated on 9 June 2025. The IronHip trial has been approved by the Danish Medicines Agency and the Danish Medical Research Ethics Committee. The protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines, the Declaration of Helsinki and the Good Clinical Practice guidelines. The trial findings will be reported according to the Consolidated Standards of Reporting Trials (CONSORT) statement in peer-reviewed journals. EU CT number: 2024-5 15 116-42-00, authorised 9 February 2025. gov: NCT06898814.
- Open Access
- 2 June 2026
- Published by Elsevier in SSRN Electronic Journal
Epidemiology of hand fractures in children - A population-based study with data from the Danish National Patient Registry
Introduction: Hand fractures are among the most common pediatric injuries, but despite their prevalence, comprehensive data on incidence and anatomical distribution remain sparse. The aim of this study was to report the incidence and anatomical distribution of hand fractures in children aged 0-15 years.Methods: This population-based register study utilized data from the Danish National Patient Registry (DNPR) over a 20-year period from 1999 to 2018. All cases of hand fractures were identified using ICD-10 codes and stratified by age, sex, anatomical site, and treatment type. Fracture incidences were calculated based on annual population data, gathered from Statistic Denmark. Data was analyzed using descriptive statistics and results presented in the form of number of cases and percentages.Results: A total of 158,070 hand fractures were recorded, with an average annual incidence of 748 per 100,000 children/year and a 17% increase in incidence over the study period. Boys accounted for 59% of cases, and the highest incidence was observed in the 12–15-year age group (51%). Finger fractures were the most common (60%) followed by metacarpal fractures (19%). There were 1% that received surgical treatment.Conclusion: We found a 17% increase in incidence over the 20-year period. The highest incidence was in the 12–15-year-olds. Boys had the majority of fractures, and finger fractures were most common. Future research should focus on refining diagnostic criteria, exploring injury mechanisms, and evaluating treatment outcomes to enhance prevention and care.
- 2 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEpidemiology of hand fractures in children - A population-based study with data from the Danish National Patient Registry
Introduction: Hand fractures are among the most common pediatric injuries, but despite their prevalence, comprehensive data on incidence and anatomical distribution remain sparse. The aim of this study was to report the incidence and anatomical distribution of hand fractures in children aged 0-15 years.Methods: This population-based register study utilized data from the Danish National Patient Registry (DNPR) over a 20-year period from 1999 to 2018. All cases of hand fractures were identified using ICD-10 codes and stratified by age, sex, anatomical site, and treatment type. Fracture incidences were calculated based on annual population data, gathered from Statistic Denmark. Data was analyzed using descriptive statistics and results presented in the form of number of cases and percentages.Results: A total of 158,070 hand fractures were recorded, with an average annual incidence of 748 per 100,000 children/year and a 17% increase in incidence over the study period. Boys accounted for 59% of cases, and the highest incidence was observed in the 12–15-year age group (51%). Finger fractures were the most common (60%) followed by metacarpal fractures (19%). There were 1% that received surgical treatment.Conclusion: We found a 17% increase in incidence over the 20-year period. The highest incidence was in the 12–15-year-olds. Boys had the majority of fractures, and finger fractures were most common. Future research should focus on refining diagnostic criteria, exploring injury mechanisms, and evaluating treatment outcomes to enhance prevention and care.
- Open Access
- 4 May 2026
- Published by BMJ in British Journal of Sports Medicine
- Vol. 60 (12) , 848-855
Randomised three-armed trial investigation of the Copenhagen Achilles tendon Rupture Treatment Algorithm (CARTA) for individualised treatment of acute Achilles tendon rupture
Objective To evaluate whether individualised treatment using the Copenhagen Achilles Rupture Treatment Algorithm (CARTA) is superior to default operative or non-operative strategies. Methods We conducted a multicentre, three-arm, randomised controlled trial. Adults with acute Achilles tendon rupture were randomised (1:1:1) to individualised CARTA, non-operative or operative treatment. In the CARTA arm, surgery was indicated if ultrasound showedResults Between May 2018 and June 2023, 970 patients were screened; 300 were randomised (male/female 76%/24%, mean age 41 (SD 1)). At 12 months, data were available for 98 CARTA (64% operated), 100 non-operative and 97 operative patients. There were no significant between-group differences in HRWT at 12 months. However, CARTA significantly reduced rerupture rates by 73% compared with non-operative treatment (3% (95% CI) (1 to 8) vs 11% (6 to 19), p=0.03), improved ATRS by 8 points (1 to 15, p=0.02) and improved ATRA by −2° (−4 to −1), p=0.01). No difference between CARTA and operative treatment was found except 36% less underwent surgery. Conclusion Individualised CARTA did not improve functional outcomes based on the HRWT at 12 months, but among secondary outcomes, it reduced rerupture rates and improved patient-reported outcomes compared with non-operative treatment and with fewer surgeries than routine operative care. Trial registration number NCT03525964.
- 4 May 2026
- Published by BMJ in British Journal of Sports Medicine
- Vol. 60 (12) , 848-855
Open AccessRandomised three-armed trial investigation of the Copenhagen Achilles tendon Rupture Treatment Algorithm (CARTA) for individualised treatment of acute Achilles tendon rupture
Objective To evaluate whether individualised treatment using the Copenhagen Achilles Rupture Treatment Algorithm (CARTA) is superior to default operative or non-operative strategies. Methods We conducted a multicentre, three-arm, randomised controlled trial. Adults with acute Achilles tendon rupture were randomised (1:1:1) to individualised CARTA, non-operative or operative treatment. In the CARTA arm, surgery was indicated if ultrasound showedResults Between May 2018 and June 2023, 970 patients were screened; 300 were randomised (male/female 76%/24%, mean age 41 (SD 1)). At 12 months, data were available for 98 CARTA (64% operated), 100 non-operative and 97 operative patients. There were no significant between-group differences in HRWT at 12 months. However, CARTA significantly reduced rerupture rates by 73% compared with non-operative treatment (3% (95% CI) (1 to 8) vs 11% (6 to 19), p=0.03), improved ATRS by 8 points (1 to 15, p=0.02) and improved ATRA by −2° (−4 to −1), p=0.01). No difference between CARTA and operative treatment was found except 36% less underwent surgery. Conclusion Individualised CARTA did not improve functional outcomes based on the HRWT at 12 months, but among secondary outcomes, it reduced rerupture rates and improved patient-reported outcomes compared with non-operative treatment and with fewer surgeries than routine operative care. Trial registration number NCT03525964.
- 4 April 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (4)
Nonselective beta-blocker eye drops and the risk of fall-related injuries: a Danish nationwide new user, active comparator propensity score matched cohort study
Background and aim: Falls in older adults are a major health concern. Risk factors include medications, but uncertainty remains about potential fall risk-increasing drugs (FRIDs). This nationwide cohort study examined whether non-selective beta-blocker eye drops (timolol) increase the risk of fall-related injuries compared to topical prostaglandin analogue (TPA) eye drops. Methods: Using registry data from all Danish residents, we included individuals aged ≥65 years who initiated timolol (n = 52 019) or TPA (n = 72 885) between 1996 and 2023. Propensity score matching was applied to balance baseline characteristics. The primary outcome covered hospital-treated fall-related injuries while the secondary outcome was fall-related fractures specifically. Results: No statistically significant differences were observed in the risk of fall-related injuries or fall-related fractures for timolol vs. TPA users at 14, 90 or 365 days of follow-up, before or after propensity score matching. Predefined subgroup analyses showed an increased risk of fall-related injuries among individuals aged ≥80 years [incidence rate ratio (IRR) 1.23, 95% CI 1.01–1.50] and among users of ≥3 FRIDs (IRR 1.20, 95% CI 1.01–1.44). Conclusion: Our findings suggest that timolol eye drops are not associated with a significantly increased risk of fall-related injuries in the overall population of older adults. However, a marginally significant increased risk of fall-related injuries was seen among the oldest individuals and those concurrently using multiple FRIDs. These findings underscore the importance of considering a patient-centred approach when prescribing medications that could be potentially harmful.
- 4 April 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (4)
Nonselective beta-blocker eye drops and the risk of fall-related injuries: a Danish nationwide new user, active comparator propensity score matched cohort study
Background and aim: Falls in older adults are a major health concern. Risk factors include medications, but uncertainty remains about potential fall risk-increasing drugs (FRIDs). This nationwide cohort study examined whether non-selective beta-blocker eye drops (timolol) increase the risk of fall-related injuries compared to topical prostaglandin analogue (TPA) eye drops. Methods: Using registry data from all Danish residents, we included individuals aged ≥65 years who initiated timolol (n = 52 019) or TPA (n = 72 885) between 1996 and 2023. Propensity score matching was applied to balance baseline characteristics. The primary outcome covered hospital-treated fall-related injuries while the secondary outcome was fall-related fractures specifically. Results: No statistically significant differences were observed in the risk of fall-related injuries or fall-related fractures for timolol vs. TPA users at 14, 90 or 365 days of follow-up, before or after propensity score matching. Predefined subgroup analyses showed an increased risk of fall-related injuries among individuals aged ≥80 years [incidence rate ratio (IRR) 1.23, 95% CI 1.01–1.50] and among users of ≥3 FRIDs (IRR 1.20, 95% CI 1.01–1.44). Conclusion: Our findings suggest that timolol eye drops are not associated with a significantly increased risk of fall-related injuries in the overall population of older adults. However, a marginally significant increased risk of fall-related injuries was seen among the oldest individuals and those concurrently using multiple FRIDs. These findings underscore the importance of considering a patient-centred approach when prescribing medications that could be potentially harmful.
- Open Access
- 3 April 2026
- Published by Elsevier in Geriatric Nursing
- Vol. 70, 104044
Healthcare professionals' perspectives on optimising hip fracture rehabilitation: Insights from the ‘Rehabilitation for Life' intervention
- 3 April 2026
- Published by Elsevier in Geriatric Nursing
- Vol. 70, 104044
Open AccessHealthcare professionals' perspectives on optimising hip fracture rehabilitation: Insights from the ‘Rehabilitation for Life' intervention
- Open Access
- 25 March 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 204-208
National rates of pediatric extremity fractures over a 20-year timespan in Denmark: a population-based descriptive cohort study
Background and purpose: Previous reports on incidences rates of Scandinavian pediatric extremity fractures have varied, as they are often anatomically specific and based on institution-specific findings. To gain knowledge of current and future burden on the healthcare system, a national cohort assessment is necessary. We aimed to assess the proportion and incidence within anatomical distributions of pediatric extremity fractures in relation to age, sex, and time trends.Methods: We retrieved a 20-year population-based cohort from the Danish National Patient Registry 1999–2018. We included all children aged 0–15 years with an extremity fracture diagnosis (ICD-10). We estimated fracture proportions and incidence rates (IRs) in different anatomical regions stratified by sex, age groups, and periods. IRs were estimated based on national population counts.Results: We included 668,595 pediatric fractures corresponding to an overall IR of 3,164 (95% confidence interval 3,157–3,172) per 100,000 persons/year. The highest proportion and IR were in the lower arm, but the proportions differed within the age groups. The IR increased with age and was higher in boys. The overall IR increased during the study period. In upper and lower leg fractures a decrease was seen, with all other anatomical sites increasing.Conclusion: We found an increased IR during the study period for all fractures except for the upper and lower leg. The study gives important knowledge to the healthcare system when coordinating the right resources.
- 25 March 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 204-208
Open AccessNational rates of pediatric extremity fractures over a 20-year timespan in Denmark: a population-based descriptive cohort study
Background and purpose: Previous reports on incidences rates of Scandinavian pediatric extremity fractures have varied, as they are often anatomically specific and based on institution-specific findings. To gain knowledge of current and future burden on the healthcare system, a national cohort assessment is necessary. We aimed to assess the proportion and incidence within anatomical distributions of pediatric extremity fractures in relation to age, sex, and time trends.Methods: We retrieved a 20-year population-based cohort from the Danish National Patient Registry 1999–2018. We included all children aged 0–15 years with an extremity fracture diagnosis (ICD-10). We estimated fracture proportions and incidence rates (IRs) in different anatomical regions stratified by sex, age groups, and periods. IRs were estimated based on national population counts.Results: We included 668,595 pediatric fractures corresponding to an overall IR of 3,164 (95% confidence interval 3,157–3,172) per 100,000 persons/year. The highest proportion and IR were in the lower arm, but the proportions differed within the age groups. The IR increased with age and was higher in boys. The overall IR increased during the study period. In upper and lower leg fractures a decrease was seen, with all other anatomical sites increasing.Conclusion: We found an increased IR during the study period for all fractures except for the upper and lower leg. The study gives important knowledge to the healthcare system when coordinating the right resources.
- Open Access
- 17 March 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 194–203
An Acta Orthopaedica educational article: Treatment of adult patients with a humeral shaft fracture
This educational review outlines the core principles of humeral shaft fracture (HSF) management and is designed for orthopedic trainees, general orthopedic surgeons, emergency physicians, and allied health professionals who participate in the acute or postoperative care of patients with HSFs. The content integrates the authors’ expert opinion with the current evidence. Humeral shaft fractures account for 1–3% of adult fractures, most often resulting from low-energy falls in older adults or high-energy trauma in younger patients. Although open fractures and neurovascular injuries are rare, primary radial nerve palsy (RNP) occurs in about 10% of cases. Diagnosis relies primarily on clinical evaluation and standard radiographs, with CT or MRI reserved for complex or pathological cases. Functional bracing has traditionally been the mainstay of nonsurgical treatment, achieving good long-term results but with nonunion rates up to 25%. Surgical fixation methods—including open reduction and internal fixation, minimally invasive plate osteosynthesis, and intramedullary nailing—allow earlier mobilization and more predictable fracture union but carry risks of iatrogenic RNP and infection. Management of primary RNP remains largely nonsurgical, with over 90% recovering spontaneously. Nonunion is frequently symptomatic and managed most often with compression plating. Surgery offers faster early recovery and lower nonunion rates, although long-term outcomes converge with successful bracing. Cost-effectiveness analyses suggest surgery may be more economical when productivity loss is considered, particularly for working-age patients. Optimal treatment selection depends on patient age, activity level, fracture characteristics, and patient preference, emphasizing shared decision-making.
- 17 March 2026
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 97, 194–203
Open AccessAn Acta Orthopaedica educational article: Treatment of adult patients with a humeral shaft fracture
This educational review outlines the core principles of humeral shaft fracture (HSF) management and is designed for orthopedic trainees, general orthopedic surgeons, emergency physicians, and allied health professionals who participate in the acute or postoperative care of patients with HSFs. The content integrates the authors’ expert opinion with the current evidence. Humeral shaft fractures account for 1–3% of adult fractures, most often resulting from low-energy falls in older adults or high-energy trauma in younger patients. Although open fractures and neurovascular injuries are rare, primary radial nerve palsy (RNP) occurs in about 10% of cases. Diagnosis relies primarily on clinical evaluation and standard radiographs, with CT or MRI reserved for complex or pathological cases. Functional bracing has traditionally been the mainstay of nonsurgical treatment, achieving good long-term results but with nonunion rates up to 25%. Surgical fixation methods—including open reduction and internal fixation, minimally invasive plate osteosynthesis, and intramedullary nailing—allow earlier mobilization and more predictable fracture union but carry risks of iatrogenic RNP and infection. Management of primary RNP remains largely nonsurgical, with over 90% recovering spontaneously. Nonunion is frequently symptomatic and managed most often with compression plating. Surgery offers faster early recovery and lower nonunion rates, although long-term outcomes converge with successful bracing. Cost-effectiveness analyses suggest surgery may be more economical when productivity loss is considered, particularly for working-age patients. Optimal treatment selection depends on patient age, activity level, fracture characteristics, and patient preference, emphasizing shared decision-making.